VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 404 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2016. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $54,809,000 | -65.8% | 539,193 | -40.0% | 3.01% | -60.7% |
Q3 2015 | $160,364,000 | +21.3% | 899,000 | +51.1% | 7.66% | +68.7% |
Q2 2015 | $132,179,000 | -29.9% | 595,000 | -37.4% | 4.54% | -35.0% |
Q1 2015 | $188,689,000 | +41.2% | 950,000 | +1.8% | 6.98% | +31.9% |
Q4 2014 | $133,593,000 | +82.9% | 933,500 | +67.7% | 5.30% | +77.4% |
Q3 2014 | $73,024,000 | -12.0% | 556,590 | -15.4% | 2.98% | -7.7% |
Q2 2014 | $82,955,000 | – | 657,750 | – | 3.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |